Lung cancer Grand Round

Grand round
Chairs: J. van Meerbeeck (Edegem (Antwerp), Belgium), P. Putora (St. Gallen, Switzerland), I. Opitz (Zurich, Switzerland), A. Fabre (Dublin 4, Ireland), M. Silva (Milan, Italy)
Aims: to test the clinical knowledge of participants in thoracic oncology; to address challenging topics in malignant thoracic diseases, including handling unfit patients with potentially curable lung cancer, wisely managing the side effects of immunotherapy in non-small cell lung cancer patients, selecting personalised multi-modal therapy options in malignant pleural mesothelioma patients and diagnosing and treating complicated mediastinal masses; to provide attendees with a unique opportunity to participate in interactive discussions with the case presenters and the on-stage multidisciplinary board panel.

A higher-risk patient with a choice between stereotactic radiotherapy and surgery D. Baldwin (Nottingham (Nottinghamshire), United Kingdom)
A challenging radiological deterioration following immunotherapy introduction A. Costantini (Paris, France)
A complex course in a pleural mesothelioma patient N. Rahman (Oxford, United Kingdom)
An uncommon mediastinal mass S. Elia (Roma (RM), Italy)